Navigation Links
AACR to honor leading researchers at breast cancer symposium
Date:10/12/2010

PHILADELPHIA The 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers during its meeting, which will be held Dec. 8-12 in the Henry B. Gonzales Convention Center, San Antonio, Texas. Klaus Pantel, M.D., Ph.D., is the recipient of the 2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure. Alan Ashworth, Ph.D., will give the 2010 AACR Distinguished Lectureship in Breast Cancer Research.

2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure

Klaus Pantel, M.D., Ph.D., professor at the Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, will receive the 2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure.

This award recognizes an investigator under 50 years of age whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of breast cancer.

Pantel is honored for his pioneering and original work on the detection of minimal residual disease and for using this information to provide improved care for breast cancer patients. His research breaks new ground toward a better understanding of the metastatic process and patient treatment.

Pantel will deliver his award lecture entitled, "Cancer Micrometastasis and Circulating Tumor Cells," on Thursday, Dec. 9, 2010, from 11:30 a.m. - 12:00 p.m. CT.

2010 AACR Distinguished Lectureship in Breast Cancer Research

Alan Ashworth Ph.D., director of the Breakthrough Research Centre at the Institute of Cancer Research, will present the 2010 AACR Distinguished Lectureship in Breast Cancer Research.

Supported by Bristol-Myers Squibb, this AACR lectureship has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment or prevention of breast cancer. The lectureship is selected by the San Antonio Breast Cancer Symposium Program Committee.

Ashworth is recognized for his contribution to the discovery of the BRCA2 gene and his team's identification of the synthetic lethality between BRCA mutations and PARP inhibitors. The high sensitivity of BRCA1 or BRCA2 mutant cells to PARP inhibitors forms the rationale behind clinical trials that are now assessing the potential of these agents.

Ashworth will deliver his lecture entitled, "Synthetic Lethal Approaches to Cancer Therapy" on Friday, Dec. 10, 2010, from 11:30 a.m. - 12:00 p.m. CT.


'/>"/>

Contact: Michele Leiberman
michele.leiberman@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Laser Spine Institute Honored at the Gridiron Greats Night of Champions
2. Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona
3. Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce
4. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
5. Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
6. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. AADR presents honorary membership to Senator Tom Harkin
9. Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut
10. Amerigroup CEO James Carlson Honored at Crystal Ball for a Cure Annual Gala
11. CareTech Solutions Honors Five Hospitals with Rising Star Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... ... Awakening” is the creation of published author, Julianne Hale, a consultant for the ... policy and counter-terrorism expert focusing on the Near East region. Julianne has ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... the Founder and Managing Member for t4 Leadership Development & Consulting. He has ... his definition of “success”: physician leadership development, servant leadership, data driven process improvement, ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Call Of Spiritual Duty”: a revelation in ... published author, C.S. Lizarde. Growing up on the streets of North Visalia, California, ... began to apply the Biblical keys to his life, he noticed immediately that opportunities ...
(Date:8/21/2017)... MO (PRWEB) , ... August 22, 2017 , ... PracticeMatch, ... fairs to help healthcare employers connect with physicians and advanced practitioners like nurse ... virtual career fairs in August through November of this year. The online career ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... I. Stevens as a 2017-2018 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting more ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... 2, 2017 Fenita J. Caldwell ... a Pinnacle Lifetime Professional in the Field of ... at Turing Pharmaceuticals, AG. Her skills and areas ... building.                ... years of experience as a highly successful sales ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today announced financial ... 2017, and updated its financial outlook for fiscal 2017. ... fiscal third quarter, Hill-Rom reported earnings of $0.09 per ... the prior-year period. These results reflect after-tax special items, ... related to the non-cash write-down of assets associated with ...
Breaking Medicine Technology: